In the hepatocellular carcinoma (HCC) cell line, the silencing of the transcriptional coactivator of the serum response factor (SRF), Megakaryoblastic Leukemia 1/2 (MKL1/2), induced a reduction of myoferlin gene expression. This evidence concerns the gene MYOF and hepatocellular carcinoma.